Sara Scapin

Private Equity

Equiter Infrastructure II's acquisition of Deenova Group, 2024
Sara advised Equiter Infrastructure II, a fund managed by Ersel AM, in connection with the FDI aspects for the acquisition of Deenova Group, an Italian company and European leader in providing automation and traceability solutions for hospitals, from HIG Capital. The transaction also involves Amundi Private Equity Italia joining the shareholding structure, in partnership with Deenova's founder Sergio Giglio.

Oaktree's sale of a controlling stake in Banca Progetto, 2024
Sara advised Funds managed by Oaktree Capital Management in connection with the sale of a controlling stake in Italian speciality bank, Banca Progetto S.p.A., to funds managed by Centerbridge Partners, L.P.

Macquarie Asset Management's €401 million sale of stake in Hydro Dolomiti Energia, 2024
Sara advised Macquarie Asset Management in connection with the €401 million agreement to sell Macquarie European Infrastructure Fund 4's 40 percent stake in Hydro Dolomiti Energia to Gruppo Dolomiti Energia, which already holds the remaining 60 percent.

Gruppo Investimenti Portuali's sale of PSA Genoa Investments NV and Vecon S.p.A. shareholdings, 2024
Sara advised Gruppo Investimenti Portuali S.p.A. (controlled by co-shareholders Infracapital, the infrastructure equity investment arm of M&G plc, and funds managed by independent French investment company InfraVia Capital Partners) in connection with the sale of the entire shareholdings held in PSA Genoa Investments NV and Vecon S.p.A., respectively, to the majority shareholder of the target companies, PSA Investment NV (controlled by PSA International Pte Ltd).

InfraCapital and InfraVia's sale of Terminal Darsena Toscana S.r.l. to the Grimaldi Group, 2024
Sara advised Infracapital, the infrastructure equity investment arm of M&G plc, and funds managed by independent French investment company InfraVia Capital Partners, co-shareholders of Gruppo Investimenti Portuali, in connection with the sale of 100 percent of the share capital in Terminal Darsena Toscana S.r.l. to the Grimaldi Group.

BC Partners' €2.1 billion acquisition of SOFIMA, 2020
Sara advised BC Partners in connection its almost €2.1 billion acquisition of an up to approximately 45 percent stake in SOFIMA, the holding company that controls IMA S.p.A.

Cobepa's strategic agreement with Enoplastic, 2019
Sara advised Cobepa, a privately-held investment company, in connection with the execution of a strategic agreement with the shareholders of Enoplastic, a leading global player in the manufacturing of closures for the wine & spirits industry.

Infracapital and InfraVia's acquisition of Gruppo Investimenti Portuali, 2017
Sara advised Infracapital and InfraVia Capital Partners in connection with the acquisition of Gruppo Investimenti Portuali S.p.A., a leading container port operator in northern Italy holding majority and minority stakes in several container terminal concessions in major Italian ports.

Summit Partners' sale of DentalPro, 2016
Sara advised Summit Partners and its portfolio company DentalPro in connection with the agreement for the acquisition of DentalPro by private equity fund BC Partners.

Strategic Corporate M&A

Huvepharma's sale of Huvepharma Italia to Olon, 2024
Sara advised Huvepharma EOOD in connection with the sale of its subsidiary, Huvepharma Italia S.r.l., to Olon S.p.A., a prominent player in the pharmaceutical industry.

Mediobanca's acquisition of Arma Partners, 2023
Sara advised Mediobanca – Banca di Credito Finanziario S.p.A. in connection with the acquisition of Arma Partners. Under the terms of the agreement, Mediobanca acquired Arma Partners to create a leading Digital Economy franchise within the CIB Division.

Verlinvest's $100 million investment in Everli, 2021
Sara advised Verlinvest S.A., a privately-owned investment group headquartered in Brussels, in connection with its US$100 million investment in Everli, Europe's leading marketplace for online grocery shopping.

Angelini Pharma's US$960 million acquisition of Arvelle Therapeutics, 2021
Sara advised Angelini Pharma S.p.A. in connection with the acquisition of Arvelle Therapeutics International GmbH, a biopharmaceutical group headquartered in Switzerland focused on developing innovative treatments for patients with central nervous system disorders, for up to US$960 million.

Gruppo Investimenti Portuali's merger with PSA Italy, 2020
Sara advised Gruppo Investimenti Portuali S.p.A. (a portfolio company of the private equity funds Infracapital and InfraVia) in connection with its merger with PSA Italy, the Italian subsidiary of the Port Authority of Singapore, which has created the largest terminal container operation managed by foreign investors in the Italian market.

Alisarda's sale of Geasar, 2020
Sara advised Alisarda S.p.A. in connection with the sale of Geasar S.p.A., the company that manages Olbia Costa Smeralda Airport in Sardinia, to Italy's largest independent infrastructure fund manager F2I.

Angelini's acquisition of ThermaCare, 2020
Sara advised Italian pharma and consumer healthcare group Angelini in connection with its worldwide acquisition, outside North America, of ThermaCare from GlaxoSmithKline (GSK). The acquisition is a key transaction in relation to the creation of the GSK/Pfizer JV for Consumer Health.

Angelini's sale and purchase of BoxaGrippal business, 2019
Sara advised Angelini S.p.A. in connection with a competitive auction for the sale and purchase of the assets related to the products BoxaGrippal tablets 200mg and 400mg, BoxaGrippal suspension and Heumann Teas, marketed or under registration by Sanofi S.A. in Germany and Austria.

HP Pelzer's acquisition of CAB Automotive, 2017
Sara advised HP Pelzer Holding GmbH in connection with its acquisition of the entire share capital of CAB Automotive Limited from Advancel Limited.